Trending News
News
News
Roche and Google.org Start Initiative for Early Discovery of New Diseases
The joint project is aimed to demonstrate the feasibility of developing a multidisciplinary surveillance, research and response system.
News
Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology
A breakthrough in transgenic animal production enables development of new human disease models.
News
Cancer's Distinctive Pattern of Gene Expression Could Aid Early Screening and Prevention
Distinctive patterns of genes turned off - or left on - in healthy versus cancerous cells could enable early screening for many common cancers, MCG scientists say.
News
PolyMedix and University of Massachusetts Amherst Receive up to $6.6 Million NIH Grant to Develop New Antibiotics
Project to develop new defensin-mimetic antimicrobial compounds for biodefense and emerging food-borne infectious diseases.
News
Single-Embryo Gene Expression
Fluidigm releases new Research Spotlight paper that reports upon the pioneering work of Dr Mylene Yao and her fellow researchers at Stanford University.
News
miRagen and Archemix to Collaborate on Conjugated Aptamer-microRNA Therapeutics
Companies collaborate on conjugated aptamer-microRNA therapies capable of intracellular delivery and subsequent microRNA targeting.
News
DxS and Epigenomics Cross-License Technology for in vitro Diagnostics
Both companies to use Scorpions® technology for diagnostic products based on DNA methylation.
News
Researchers to Decode Antarctic Ice Metagenome with the 454 Sequencing System
Researchers at the Alfred Wegener Institute plans to perform the first metagenomic analysis of the diverse set of organisms living within arctic sea ice.
News
Horizon Discovery and DxS to Lead the Way in Setting Standards for Companion Diagnostic Tests
Horizon to develop a panel of human isogenic cell models that will be used to further develop DxS’ TheraScreen® range of clinical diagnostic kits.
News
Junying Yu, Leading Stem Cell Researcher, Joins Cellular Dynamics International
Dr. Yu’s scientific will help accelerate the company to harness the power of iPS cells to reproducibly differentiate into essential cell types.
Advertisement